Business Description
Naturewise Biotech & Medicals Corp
NAICS : 325411
SIC : 2833
ISIN : TW0004732003
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 58.59 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.31 | |||||
Interest Coverage | 92.81 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 12.76 | |||||
Beneish M-Score | -3.03 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -19.8 | |||||
3-Year EBITDA Growth Rate | -34.4 | |||||
3-Year EPS without NRI Growth Rate | -46.7 | |||||
3-Year FCF Growth Rate | 3.9 | |||||
3-Year Book Growth Rate | 1.9 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 50.84 | |||||
9-Day RSI | 47.99 | |||||
14-Day RSI | 48.07 | |||||
6-1 Month Momentum % | 1.2 | |||||
12-1 Month Momentum % | -6.81 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 12.46 | |||||
Quick Ratio | 11.07 | |||||
Cash Ratio | 9.77 | |||||
Days Inventory | 241.31 | |||||
Days Sales Outstanding | 39.62 | |||||
Days Payable | 25.3 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.8 | |||||
Dividend Payout Ratio | 1.61 | |||||
Forward Dividend Yield % | 0.8 | |||||
5-Year Yield-on-Cost % | 0.8 | |||||
Shareholder Yield % | 0.43 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 54.92 | |||||
Operating Margin % | 3.55 | |||||
Net Margin % | 7.02 | |||||
FCF Margin % | 22.36 | |||||
ROE % | 2.5 | |||||
ROA % | 2.27 | |||||
ROIC % | 4.27 | |||||
3-Year ROIIC % | -171.15 | |||||
ROC (Joel Greenblatt) % | 25.72 | |||||
ROCE % | 2.55 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 81.62 | |||||
PE Ratio without NRI | 81.62 | |||||
Price-to-Owner-Earnings | 20.97 | |||||
PS Ratio | 5.62 | |||||
PB Ratio | 1.95 | |||||
Price-to-Tangible-Book | 2.07 | |||||
Price-to-Free-Cash-Flow | 25.13 | |||||
Price-to-Operating-Cash-Flow | 24.83 | |||||
EV-to-EBIT | 46.42 | |||||
EV-to-EBITDA | 28.07 | |||||
EV-to-Revenue | 3.39 | |||||
EV-to-FCF | 14.87 | |||||
Price-to-Projected-FCF | 1.91 | |||||
Price-to-Median-PS-Value | 1.08 | |||||
Price-to-Graham-Number | 2.74 | |||||
Price-to-Net-Current-Asset-Value | 2.2 | |||||
Price-to-Net-Cash | 2.89 | |||||
Earnings Yield (Greenblatt) % | 2.15 | |||||
FCF Yield % | 4.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Naturewise Biotech & Medicals Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 224.575 | ||
EPS (TTM) (NT$) | 0.31 | ||
Beta | 1.4 | ||
Volatility % | 31.51 | ||
14-Day RSI | 48.07 | ||
14-Day ATR (NT$) | 0.932628 | ||
20-Day SMA (NT$) | 25.5825 | ||
12-1 Month Momentum % | -6.81 | ||
52-Week Range (NT$) | 22.05 - 28.6 | ||
Shares Outstanding (Mil) | 49.29 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Naturewise Biotech & Medicals Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Naturewise Biotech & Medicals Corp Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Naturewise Biotech & Medicals Corp Frequently Asked Questions
What is Naturewise Biotech & Medicals Corp(ROCO:4732)'s stock price today?
When is next earnings date of Naturewise Biotech & Medicals Corp(ROCO:4732)?
Does Naturewise Biotech & Medicals Corp(ROCO:4732) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |